Nuclear Medicine Faculty

Full-Time Faculty

Khalid Makhdomi, MBBS, DNB (Nuclear Medicine)  
Assistant Professor

Dr. Khalid, a Consultant Nuclear Medicine Physician, is the Section Head of Nuclear Medicine. He graduated with an MBBS degree from the University of Kashmir in 1986 and received a Diplomate in Nuclear Medicine from the National Board of Examinations in India in 1996. Dr. Khalid has been associated with the Nuclear Medicine section its inception in 2008 and played a major role in setting up the Unit. Before that, he was working at the Medical Imaging and Therapeutic Centre in Nairobi since 1998, where he was instrumental in setting up the first full-fledged Nuclear Medicine unit in the country. He had a long stint as the Radiology Program Director from 2008 to 2017. He is a member of several committees including the Departmental Residency Training Committee, Department Board of Examiners, and the hospital Radiation Safety Committee. He is a past Chairman of the Kenya Association of Radiologists and has been a longstanding active member of the Association, having continuously served on the Council for the last fifteen years. He has had several publications in peer-reviewed journals and has presented his research work at several international conferences. His research interests include lymphoscintigraphy for lymphedema and sentinel node detection, and Iodine-131 therapy for hyperthyroidism.


  1. ‘Lower limb lymphoscintigraphy patterns among patients with lower limb lymphedema: a pictorial essay’ Edward C. Nganga, Samuel Gitau, and Khalid Makhdomi. Clin Transl Imaging DOI 10.1007/s40336-018-0266-y.

  2. ‘Sentinel Lymph Node Biopsy Pathology and 2-Year Postsurgical Recurrence of Breast Cancer in Kenyan Women’ Nathan R. Brand, Ronald Wasike, Khalid Makhdomi, Rs Chauhan, Zahir Moloo, Samuel M. Gakinya, Alfred I. Neugut, Jo Anne Zujewski, Shahin Sayed. J Glob Oncol Vol 4, Pp 1-7 (2017).

  3. ‘Prostate-specific Antigen as a Risk Factor for Skeletal Metastasis in Native Ethnic African Men with Prostate Cancer: A Case-control Study’ Ayman M. Qureshi, Khalid Makhdomi, and William Stones in World J Nucl Med. 2017 Jan-Mar; 16(1):26-32.

  4. ‘Sentinel node imprint cytology for the diagnosis of sentinel node metastases in early breast cancer in the absence of frozen section facility: a validation study in a resource-limited setting’, S. Sayed Mohamed, Neeta Kumar, Zahir Moloo, F. Rana, Khalid Makhdomi, Ronald Wasike, Rs Chauhan. Acta cytological, May 2010, 54(3):417-417

  5. ‘Cholangiopathy associated with portal hypertension: diagnostic evaluation and clinical implications’. Geeta H. Malkan, Shobna J. Bhatia, Khalid Bashir, Raju Khemani, Philip Abraham, Malan S. Gandhi, Ravikumar Radhakrishnan. Gastrointestinal Endoscopy, March 1999, Part 1, Vol. 49, No. 3, 344-8.

  6. 'Hepatic perfusion index in portal hypertension of cirrhotic and non-cirrhotic etiologies'. S. V. Shikare, Khalid Bashir, P. Abraham, G. H. Tilve. Nuclear Medicine Communications, 1996, 17, 520-522.

  7. 'Early diagnosis of myositis ossificans with 99mTc Methylene diphosphonate bone scan'. S. Shikare, Hemant Pandit, Khalid Bashir, G. H. Tilve. Indian Journal of Nuclear Medicine, Vol. 10, No. 2, April 1995, 94-95.

  8. ‘Detection of medullary carcinoma of thyroid, with liver metastasis, using (99m) Tc DMSA(V) scintigraphy’. Shikare S., Bashir K., Menon PS., Bapat RD., Tilve GH. Journal Of Postgraduate Medicine, 1995, 41(1), 8-11.

  9. 'Role of 99mTc-DTPA scintigraphy in pre-op. (diagnostic) and post-op. (shunt patency evaluation) cases of hydrocephalus in children'. Aleem Jan and Khalid Bashir. Indian Journal of Nuclear Medicine, Vol. 6, No. 3, July 1991, 21-27.